Literature DB >> 18008244

Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites.

Rosalynn Ord1, Neal Alexander, Sam Dunyo, Rachel Hallett, Musa Jawara, Geoffrey Targett, Christopher J Drakeley, Colin J Sutherland.   

Abstract

BACKGROUND: Observations in natural Plasmodium falciparum populations after removal of failing drugs suggest that there is a fitness cost of drug resistance.
METHODS: To examine the effect of transient removal of drug pressure, we analyzed seasonal changes in the prevalence of chloroquine (CQ)-resistant parasite genotypes in The Gambia. Parasite isolates from 441 children presenting with uncomplicated falciparum malaria over 5 seasons (1998-2002) were linked to weekly rainfall data.
RESULTS: The prevalence of CQ-resistant parasites increased slightly over 5 years, with the 76T allele of pfcrt (odds ratio [OR] per year, 1.16; P=.03) and the 86Y allele of pfmdr1 (OR per year, 1.18; P=.02) becoming significantly more common. However, intraseasonal analysis showed that these alleles decreased in prevalence each dry season. Wild-type parasites with respect to both loci predominated as transmission began each year, with resistant parasites becoming more common as drug use increased. This pattern was seen for both pfcrt-76T (OR per week, 1.09; P=.001) and pfmdr1-86Y (OR per week, 1.07; P=.001) and could not be explained by seasonal changes in the clonal complexity of infections.
CONCLUSIONS: The fitness cost of CQ resistance works against the persistence of resistant parasites through the dry season.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18008244     DOI: 10.1086/522154

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.

Authors:  Silvie Huijben; William A Nelson; Andrew R Wargo; Derek G Sim; Damien R Drew; Andrew F Read
Journal:  Evolution       Date:  2010-08-19       Impact factor: 3.694

2.  Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes.

Authors:  Andrea Ecker; Viswanathan Lakshmanan; Photini Sinnis; Isabelle Coppens; David A Fidock
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

3.  Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?

Authors:  Colin J Sutherland; Hamza Babiker; Margaret J Mackinnon; Lisa Ranford-Cartwright; Badria Babiker El Sayed
Journal:  Parasitology       Date:  2011-08-03       Impact factor: 3.234

4.  The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.

Authors:  S Huijben; D G Sim; W A Nelson; A F Read
Journal:  J Evol Biol       Date:  2011-08-23       Impact factor: 2.411

5.  Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012.

Authors:  Irina Tatiana Jovel; Poul-Erik Kofoed; Lars Rombo; Amabelia Rodrigues; Johan Ursing
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

6.  Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda.

Authors:  Stephen Tukwasibwe; Levi Mugenyi; George W Mbogo; Sheila Nankoberanyi; Catherine Maiteki-Sebuguzi; Moses L Joloba; Samuel L Nsobya; Sarah G Staedke; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2014-01-19       Impact factor: 5.226

7.  Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Yngve Bergqvist; Lars Rombo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

8.  Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.

Authors:  Nahla B Gadalla; Salah Eldin Elzaki; Ebtihal Mukhtar; David C Warhurst; Badria El-Sayed; Colin J Sutherland
Journal:  Malar J       Date:  2010-03-12       Impact factor: 2.979

9.  Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.

Authors:  John N Waitumbi; Samuel B Anyona; Carol W Hunja; Carolyne M Kifude; Mark E Polhemus; Douglas S Walsh; Chris F Ockenhouse; D Gray Heppner; Amanda Leach; Marc Lievens; W Ripley Ballou; Joe D Cohen; Colin J Sutherland
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

10.  No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Lars Rombo
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.